Ionis analyst coverage
Web10 apr. 2024 · Finally, StockNews.com initiated coverage on shares of Ionis Pharmaceuticals in a research report on Thursday, March 16th. They issued a "hold" rating for the company. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the stock. Web22 mrt. 2024 · Ionis Pharmaceuticals Price Performance. NASDAQ IONS opened at $35.62 on Tuesday. Ionis Pharmaceuticals has a fifty-two week low of $31.46 and a fifty-two …
Ionis analyst coverage
Did you know?
Web11 apr. 2024 · Analysts Have Conflicting Sentiments on These Healthcare Companies: Centene (CNC), Ionis Pharmaceuticals (IONS) and Biogen (BIIB) Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Centene (CNC – Research Report), Ionis … tipranks.com - Brian Anderson • 2h Read more on … Web6 apr. 2024 · According to analysts, Ionis Pharmaceuticals's stock has a predicted upside of 20.00% based on their 12-month price targets. What analysts cover Ionis …
Web26 jul. 2024 · To learn more about Ionis visit www.ionispharma.com and follow us on twitter @ionispharma. Ionis' Forward-looking Statement. This press release includes forward … Web28 feb. 2024 · After the latest results, the consensus from Ionis Pharmaceuticals's 18 analysts is for revenues of US$781.8m in 2024, ... (with analyst coverage) ...
Web13 apr. 2024 · Craig Hallum initiated coverage on shares of LuxUrban Hotels (NASDAQ:LUXH – Get Rating) in a report issued on Monday, The Fly reports. The brokerage issued a buy rating and a $10.00 price objective on the stock. Separately, Maxim Group raised their price target on shares of LuxUrban Hotels from $6.00 to $7.00 and … Web5 mrt. 2024 · C iti analyst Joel Beatty began coverage of the stock with a Buy rating.. Citi analyst Joel Beatty began coverage of the stock with a Buy rating. Ionis …
Web9 nov. 2024 · Ionis' revenue was comprised of the following: Total revenue for the three and nine months ended September 30, 2024 increased 20 percent and 18 percent compared …
Web20 mrt. 2024 · Ionis Pharmaceuticals (NASDAQ:IONS) Now Covered by Analysts at StockNews.com Posted by MarketBeat News on Mar 20th, 2024 StockNews.com started … citi trends holly springs msWeb15 dec. 2024 · Equities researchers at UBS Group started coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS) in a research report issued to clients and investors on … citi trends human resources numberWeb11 apr. 2024 · Fintel reports that on April 11, 2024, Morgan Stanley maintained coverage of Ionis Pharmaceuticals (NASDAQ:IONS) with a Equal-Weight recommendation. Analyst … citi trends hours todayWeb1 dag geleden · The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details. citi trends human resourcesWebAnalyst Ratings Ionis Pharmaceuticals Inc. Stock Price Target IONS Advertisement Options Overview Research & Ratings Stocks: Real-time U.S. stock quotes reflect trades … citi trends inc staff human resourceWeb9 sep. 2024 · In recent trading, shares of Ionis Pharmaceuticals Inc (Symbol: IONS) have crossed above the average analyst 12-month target price of $44.08, changing hands for … citi trends inc investor relationsWeb12 apr. 2024 · According to analysts' consensus price target of $45.17, Ionis Pharmaceuticals has a forecasted upside of 22.8% from its current price of $36.79. … citi trends holiday hours